|
1
|
Prabhakar BS, Bahn RS and Smith TJ:
Current perspective on the pathogenesis of Graves' disease and
ophthalmopathy. Endocr Rev. 24:802–835. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bahn RS: Graves' ophthalmopathy. N Engl J
Med. 362:726–738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Garrity JA and Bahn RS: Pathogenesis of
graves ophthalmopathy: Implications for prediction, prevention, and
treatment. Am J Ophthalmol. 142:147–153. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wiersinga WM and Bartalena L: Epidemiology
and prevention of Graves' ophthalmopathy. Thyroid. 12:855–860.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ajjan RA and Weetman AP: New understanding
of the role of cytokines in the pathogenesis of Graves'
ophthalmopathy. J Endocrinol Invest. 27:237–245. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kazim M, Goldberg RA and Smith TJ:
Insights into the pathogenesis of thyroid-associated orbitopathy:
Evolving rationale for therapy. Arch Ophthalmol. 120:380–386. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smith TJ: Orbital fibroblasts exhibit a
novel pattern of responses to proinflammatory cytokines: Potential
basis for the pathogenesis of thyroid-associated ophthalmopathy.
Thyroid. 12:197–203. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee WM, Paik JS, Cho WK, Oh EH, Lee SB and
Yang SW: Rapamycin enhances TNF-α-induced secretion of IL-6 and
IL-8 through suppressing PDCD4 degradation in orbital fibroblasts.
Curr Eye Res. 38:699–706. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoon JS, Chae MK, Lee SY and Lee EJ:
Anti-inflammatory effect of quercetin in a whole orbital tissue
culture of Graves' orbitopathy. Br J Ophthalmol. 96:1117–1121.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Heufelder AE and Bahn RS: Elevated
expression in situ of selectin and immunoglobulin superfamily type
adhesion molecules in retroocular connective tissues from patients
with Graves' ophthalmopathy. Clin Exp Immunol. 91:381–389. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kahaly G, Hansen C, Felke B and Dienes HP:
Immunohistochemical staining of retrobulbar adipose tissue in
Graves' ophthalmopathy. Clin Immunol Immunopathol. 73:53–62. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Konuk EB, Konuk O, Misirlioglu M, Menevse
A and Unal M: Expression of cyclooxygenase-2 in orbital
fibroadipose connective tissues of Graves' ophthalmopathy patients.
Eur J Endocrinol. 155:681–685. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang HS, Cao HJ, Winn VD, Rezanka LJ,
Frobert Y, Evans CH, Sciaky D, Young DA and Smith TJ: Leukoregulin
induction of prostaglandin-endoperoxide H synthase-2 in human
orbital fibroblasts. An in vitro model for connective tissue
inflammation. J Biol Chem. 271:22718–22728. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bartalena L, Pinchera A and Marcocci C:
Management of Graves' ophthalmopathy: Reality and perspectives.
Endocr Rev. 21:168–199. 2000.PubMed/NCBI
|
|
15
|
Kannaiyan R, Shanmugam MK and Sethi G:
Molecular targets of celastrol derived from Thunder of God Vine:
Potential role in the treatment of inflammatory disorders and
cancer. Cancer Lett. 303:9–20. 2011. View Article : Google Scholar
|
|
16
|
Salminen A, Lehtonen M, Paimela T and
Kaarniranta K: Celastrol: Molecular targets of Thunder God Vine.
Biochem Biophys Res Commun. 394:439–442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cascão R, Vidal B, Raquel H, Neves-Costa
A, Figueiredo N, Gupta V, Fonseca JE and Moita LF: Effective
treatment of rat adjuvant-induced arthritis by celastrol. Autoimmun
Rev. 11:856–862. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li H, Zhang YY, Tan HW, Jia YF and Li D:
Therapeutic effect of tripterine on adjuvant arthritis in rats. J
Ethnopharmacol. 118:479–484. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim DY, Park JW, Jeoung D and Ro JY:
Celastrol suppresses allergen-induced airway inflammation in a
mouse allergic asthma model. Eur J Pharmacol. 612:98–105. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li H, Zhang YY, Huang XY, Sun YN, Jia YF
and Li D: Beneficial effect of tripterine on systemic lupus
erythematosus induced by active chromatin in BALB/c mice. Eur J
Pharmacol. 512:231–237. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim DH, Shin EK, Kim YH, Lee BW, Jun JG,
Park JH and Kim JK: Suppression of inflammatory responses by
celastrol, a quinone methide triterpenoid isolated from Celastrus
regelii. Eur J Clin Invest. 39:819–827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sen T, Dutta A and Chatterjee A:
Epigallocatechin-3-gallate (EGCG) downregulates gelatinase-B
(MMP-9) by involvement of FAK/ERK/NFkappaB and AP-1 in the human
breast cancer cell line MDA-MB-231. Anticancer Drugs. 21:632–644.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ghosh S, May MJ and Kopp EB: NF-kappa B
and Rel proteins: evolutionarily conserved mediators of immune
responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee JH, Koo TH, Yoon H, Jung HS, Jin HZ,
Lee K, Hong YS and Lee JJ: Inhibition of NF-kappa B activation
through targeting I kappa B kinase by celastrol, a quinone methide
triterpenoid. Biochem Pharmacol. 72:1311–1321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sethi G, Ahn KS, Pandey MK and Aggarwal
BB: Celastrol, a novel triterpene, potentiates TNF-induced
apoptosis and suppresses invasion of tumor cells by inhibiting
NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB
activation. Blood. 109:2727–2735. 2007.
|
|
26
|
Yiu WH, Wong DW, Chan LY, Leung JC, Chan
KW, Lan HY, Lai KN and Tang SC: Tissue kallikrein mediates
pro-inflammatory pathways and activation of protease-activated
receptor-4 in proximal tubular epithelial cells. PLoS One.
9:e888942014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang C, Du W, Dong Q, Liu X, Li W, Wang Y
and Gao G: Expression levels and genetic polymorphisms of
interleukin-2 and interleukin-10 as biomarkers of Graves' disease.
Exp Ther Med. 9:925–930. 2015.PubMed/NCBI
|
|
28
|
Zhao LQ, Wei RL, Cheng JW, Cai JP and Li
Y: The expression of intercellular adhesion molecule-1 induced by
CD40-CD40 L ligand signaling in orbital fibroblasts in patients
with Graves' ophthalmopathy. Invest Ophthalmol Vis Sci.
51:4652–4660. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Choi YH, Back KO, Kim HJ, Lee SY and Kook
KH: Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production
in orbital fibroblasts through suppression of NF-κB activity. Exp
Eye Res. 113:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Chen LF and Greene WC: Shaping the nuclear
action of NF-kappaB. Nat Rev Mol Cell Biol. 5:392–401. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoon JS, Lee HJ, Choi SH, Chang EJ, Lee SY
and Lee EJ: Quercetin inhibits IL-1β-induced inflammation,
hyaluronan production and adipogenesis in orbital fibroblasts from
Graves' orbitopathy. PLoS One. 6:e262612011. View Article : Google Scholar
|
|
33
|
Smith TJ: Unique properties of orbital
connective tissue underlie its involvement in Graves' disease.
Minerva Endocrinol. 28:213–222. 2003.PubMed/NCBI
|
|
34
|
Smith TJ: Novel aspects of orbital
fibroblast pathology. J Endocrinol Invest. 27:246–253. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Smith RS, Smith TJ, Blieden TM and Phipps
RP: Fibroblasts as sentinel cells. Synthesis of chemokines and
regulation of inflammation. Am J Pathol. 151:317–322.
1997.PubMed/NCBI
|
|
36
|
Cao HJ, Wang HS, Zhang Y, Lin HY, Phipps
RP and Smith TJ: Activation of human orbital fibroblasts through
CD40 engagement results in a dramatic induction of hyaluronan
synthesis and prostaglandin endoperoxide H synthase-2 expression.
Insights into potential pathogenic mechanisms of thyroid-associated
ophthalmopathy. J Biol Chem. 273:29615–29625. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wakelkamp IM, Bakker O, Baldeschi L,
Wiersinga WM and Prummel MF: TSH-R expression and cytokine profile
in orbital tissue of active vs. Inactive Graves' ophthalmopathy
patients. Clin Endocrinol (Oxf). 58:280–287. 2003. View Article : Google Scholar
|
|
38
|
Chen B, Tsui S and Smith TJ: IL-1 beta
induces IL-6 expression in human orbital fibroblasts:
Identification of an anatomic-site specific phenotypic attribute
relevant to thyroid-associated ophthalmopathy. J Immunol.
175:1310–1319. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hwang CJ, Afifiyan N, Sand D, Naik V, Said
J, Pollock SJ, Chen B, Phipps RP, Goldberg RA, Smith TJ and Douglas
RS: Orbital fibroblasts from patients with thyroid-associated
ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8 and
MCP-1. Invest Ophthalmol Vis Sci. 50:2262–2268. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kaback LA and Smith TJ: Expression of
hyaluronan synthase messenger ribonucleic acids and their induction
by interleukin-1beta in human orbital fibroblasts: Potential
insight into the molecular pathogenesis of thyroid-associated
ophthalmopathy. J Clin Endocrinol Metab. 84:4079–4084.
1999.PubMed/NCBI
|
|
41
|
Sikorski EE, Hallmann R, Berg EL and
Butcher EC: The Peyer's patch high endothelial receptor for
lymphocytes, the mucosal vascular addressin, is induced on a murine
endothelial cell line by tumor necrosis factor-alpha and IL-1. J
Immunol. 151:5239–5250. 1993.PubMed/NCBI
|
|
42
|
Lie PP, Cheng CY and Mruk DD: The biology
of interleukin-1: Emerging concepts in the regulation of the actin
cytoskeleton and cell junction dynamics. Cell Mol Life Sci.
69:487–500. 2012. View Article : Google Scholar :
|
|
43
|
Tak PP and Firestein GS: NF-kappaB: A key
role in inflammatory diseases. J Clin Invest. 107:7–11. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kiaei M, Kipiani K, Petri S, Chen J,
Calingasan NY and Beal MF: Celastrol blocks neuronal cell death and
extends life in transgenic mouse model of amyotrophic lateral
sclerosis. Neuro-degener Dis. 2:246–254. 2005. View Article : Google Scholar
|
|
45
|
He D, Xu Q, Yan M, Zhang P, Zhou X, Zhang
Z, Duan W, Zhong L, Ye D and Chen W: The NF-kappa B inhibitor,
celastrol, could enhance the anti-cancer effect of gambogic acid on
oral squamous cell carcinoma. BMC Cancer. 9:3432009. View Article : Google Scholar :
|
|
46
|
Zhou LL, Lin ZX, Fung KP, Cheng CH, Che
CT, Zhao M, Wu SH and Zuo Z: Celastrol-induced apoptosis in human
HaCaT keratinocytes involves the inhibition of NF-κB activity. Eur
J Pharmacol. 670:399–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
